The acute promyelocytic leukaemia success story: curing leukaemia through targeted therapies
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The acute promyelocytic leukaemia success story: curing leukaemia through targeted therapies
Authors
Keywords
-
Journal
JOURNAL OF INTERNAL MEDICINE
Volume 276, Issue 1, Pages 61-70
Publisher
Wiley
Online
2014-03-18
DOI
10.1111/joim.12208
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of a promyelocytic leukemia–tumor protein 53 axis underlies acute promyelocytic leukemia cure
- (2014) Julien Ablain et al. NATURE MEDICINE
- OBFC2A/RARA: a novel fusion gene in variant acute promyelocytic leukemia
- (2013) D. Won et al. BLOOD
- SUMOylation of p53 mediates interferon activities
- (2013) Laura Marcos-Villar et al. CELL CYCLE
- Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha
- (2013) Rabab M. El Eit et al. INTERNATIONAL JOURNAL OF CANCER
- Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies
- (2013) Julien Ablain et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Corepressor CTBP2 Is a Coactivator of Retinoic Acid Receptor/Retinoid X Receptor in Retinoic Acid Signaling
- (2013) Prashanth Kumar Bajpe et al. MOLECULAR AND CELLULAR BIOLOGY
- Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
- (2013) Francesco Lo-Coco et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudin induces p53 signaling and apoptosis in HTLV-1-infected cells
- (2013) Shuichi Kinpara et al. Retrovirology
- Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups
- (2013) L Riva et al. Blood Cancer Journal
- Acute promyelocytic leukemia, arsenic, and PML bodies
- (2012) Hugues de Thé et al. JOURNAL OF CELL BIOLOGY
- Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL
- (2012) M Leiva et al. LEUKEMIA
- Pml represses tumour progression through inhibition of mTOR
- (2011) Rosa Bernardi et al. EMBO Molecular Medicine
- Regulation of E2Fs and senescence by PML nuclear bodies
- (2011) M. Vernier et al. GENES & DEVELOPMENT
- Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression
- (2011) Lukas D. Wartman et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase II Study of Single-Agent Arsenic Trioxide for the Front-Line Therapy of Acute Promyelocytic Leukemia
- (2011) Ardeshir Ghavamzadeh et al. JOURNAL OF CLINICAL ONCOLOGY
- Curing APL through PML/RARA degradation by As2O3
- (2011) Valerie Lallemand-Breitenbach et al. TRENDS IN MOLECULAR MEDICINE
- BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia
- (2010) Y. Yamamoto et al. BLOOD
- Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein
- (2010) P. Isakson et al. BLOOD
- PML-RARα/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia
- (2010) Joost H.A. Martens et al. CANCER CELL
- Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up Data
- (2010) Vikram Mathews et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia
- (2010) Hiba El Hajj et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: A systematic review
- (2010) Amer Beitinjaneh et al. LEUKEMIA RESEARCH
- Dual Role of p53 in Innate Antiviral Immunity
- (2010) Carmen Rivas et al. Viruses-Basel
- Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)
- (2009) G. Kchour et al. BLOOD
- Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
- (2009) J. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The seventh pathogenic fusion gene FIP1L1-RARA was isolated from a t(4;17)-positive acute promyelocytic leukemia
- (2008) T. Kondo et al. HAEMATOLOGICA
- MBD3, a Component of the NuRD Complex, Facilitates Chromatin Alteration and Deposition of Epigenetic Marks
- (2008) L. Morey et al. MOLECULAR AND CELLULAR BIOLOGY
- RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
- (2008) Michael H. Tatham et al. NATURE CELL BIOLOGY
- Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
- (2008) Valérie Lallemand-Breitenbach et al. NATURE CELL BIOLOGY
- Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
- (2008) Rihab Nasr et al. NATURE MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started